Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic review

A Vaughan, EF Duffell, GS Friedl, DS Lemos, T Funk, A Nardone, M Valenciano, L Subissi, I Bergeri, E Broberg, P Penttinen, R Pebody, M Keramarou
doi: https://doi.org/10.1101/2021.12.02.21266897
Back to top
Posted December 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic review
A Vaughan, EF Duffell, GS Friedl, DS Lemos, T Funk, A Nardone, M Valenciano, L Subissi, I Bergeri, E Broberg, P Penttinen, R Pebody, M Keramarou
medRxiv 2021.12.02.21266897; doi: https://doi.org/10.1101/2021.12.02.21266897
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area